Inge L. Huibregtse

Neoadjuvant Immunotherapy in Locally Advanced Mismatch Repair–Deficient Colon Cancer

Myriam Chalabi, Y.L. Verschoor, Pedro Batista Tan et al. · New England Journal of Medicine · 2024 · 305 citations · Full text

Induction of Ovalbumin-Specific Tolerance by Oral Administration of Lactococcus lactis Secreting Ovalbumin

Inge L. Huibregtse, Veerle Snoeck, An De Creus et al. · Gastroenterology · 2007 · 106 citations · Full text

Probiotic, Health Sciences, Medicine +8

Long-term Quality of Life and Functional Outcome of Patients With Rectal Cancer Following a Watch-and-Wait Approach

Petra A. Custers, Marit E. van der Sande, Brechtje A. Grotenhuis et al. · JAMA Surgery · 2023 · 106 citations · Full text

Neoadjuvant nivolumab, ipilimumab, and celecoxib in MMR-proficient and MMR-deficient colon cancers: Final clinical analysis of the NICHE study.

Y.L. Verschoor, José van den Berg, Geerard L. Beets et al. · Journal of Clinical Oncology · 2022 · 92 citations

Surgical Oncology, Immunology, Pathology +18

Induction of Antigen-Specific Tolerance by Oral Administration of <i>Lactococcus lactis</i> Delivered Immunodominant DQ8-Restricted Gliadin Peptide in Sensitized Nonobese Diabetic Ab° Dq8 Transgenic Mice

Inge L. Huibregtse, Eric Marietta, Shadi Rashtak et al. · The Journal of Immunology · 2009 · 85 citations · Full text

Immune Tolerance, Immunology, Immune Regulation +23